Showing results (981-990 of 2,487) with videos related to

Sort By:
Pageof 249
European Journal of Dermatology : EJD|December 5, 2022
Ixekizumab four-week dosing is comparable to two-week dosing in psoriasis patients and reduces treatment costs: experience in a real-world setting over a 12-week periodYing Li, Yingyuan Yu, Yu Wang, et al.
European Journal of Dermatology : EJD|December 5, 2022
Effects of the COVID-19 pandemic on the diagnosis of malignant melanoma: a retrospective studyJohanna Spurny-Dworak, Andreas Steiner, Friedrich Breier, et al.
European Journal of Dermatology : EJD|January 24, 2019
The microbiome and its relevance in complex woundsFrancesco Drago, Lodovica Gariazzo, Margherita Cioni, et al.
European Journal of Dermatology : EJD|July 26, 2021
β2-adrenoreceptors control human skin microvascular reactivityAnselm Morell, Javier Milara, Laurabel Gozalbes, et al.
European Journal of Dermatology : EJD|July 26, 2021
Increased prevalence of irritant hand eczema in health care workers in a dermatological clinic due to increased hygiene measures during the SARS-CoV-2 pandemicMarkus Reinholz, Benjamin Kendziora, Surina Frey, et al.
European Journal of Dermatology : EJD|April 17, 2013
Signaling moderation: TGF-β in exocrine gland development, maintenance, and regulationAdrian J McNairn, Marion Brusadelli, Géraldine Guasch
European Journal of Dermatology : EJD|April 6, 2013
Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelersSaskia Eichner, Sybille Thoma-Uszynski, Ilka Herrgott, et al.
European Journal of Dermatology : EJD|April 6, 2013
Influence of psoriasis on workKalle Mattila, Mauri Leino, Anssi Mustonen, et al.
European Journal of Dermatology : EJD|December 15, 2012
Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomasRoberto Betti, Carlo Crosti, Simona Ghiozzi, et al.
European Journal of Dermatology : EJD|February 13, 2013
The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-upDavid Farhi, Christophe Bedane, Jacques Savary, et al.
Pageof 249